Greenwich LifeSciences (GLSI) Live Share Price, Invest From India

Greenwich LifeSciences Stock Performance

as on October 24, 2026 at 6:21 am IST

Day's Low
Day's High
$14.95
Day's Price Range
$16.09
$15.79
5.32%
Downside
1.90%
Upside
52 Week's Low
52 Week's High
$7.78
52-Week Price Range
$34.10
$15.79
50.73%
Downside
115.96%
Upside

Greenwich LifeSciences share price movements today

Previous Close: $15.48
Open: $15.30
Volume: 207.5K
Market Cap: $243.2M
Day's Low - High: $14.95 - $16.09
52 Week Low - High: $7.78 - $34.10

Greenwich LifeSciences Historical Returns

1 Month Return: -11.59 %
3 Month Return: + 17.36 %
1 Year Return: + 68.44 %
3 Year Return: + 99.23 %
5 Year Return: -56.33 %

Greenwich LifeSciences Stock Fundamentals & Key Indicators

Check Greenwich LifeSciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$243.2M

EPS (TTM)

-1.54

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-10.76

Industry PE ratio

-3.14

PEG Ratio

0.82

EBITDA

-21.7M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-793.76%

Greenwich LifeSciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Greenwich LifeSciences with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Greenwich LifeSciences	Buy	$243.2M	-56.33%	-10.76	0.00%	0.00%
Moderna	Neutral	$98.1B	-37.95%	-30.80	-12.57%	0.00%
BeOne Medicines	StrongBuy	$44.0B	NA	27.47	87.82%	0.00%
Vertex Pharmaceuticals	StrongBuy	$132.9B	191.61%	30.28	86.04%	0.00%
Regeneron	Buy	$83.1B	43.11%	19.24	84.86%	0.46%

Stock Returns calculator for Greenwich LifeSciences Stock including INR - Dollar returns

The Greenwich LifeSciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Greenwich LifeSciences investment value today

Current value as on today

₹1,85,834

Returns

₹85,834

(+85.83%)

Returns from Greenwich LifeSciences Stock

₹71,817 (+71.82%)

Dollar Impact

₹14,017 (+14.02%)

Analyst Recommendation on Greenwich LifeSciences Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Greenwich LifeSciences. Average target price of $57

Greenwich LifeSciences Share Price Target

Get share price movements and forecasts by analysts on Greenwich LifeSciences.

What analysts predicted

72.3%UPSIDE

Target Price

$57

Current Price

$15.79

Analyzed by

7 Analysts

Target

$57.00

Greenwich LifeSciences target price $57, a slight upside of 72.3% compared to current price of $15.79. According to 7 analysts rating.

Indian Investors' Interest in Greenwich LifeSciences Stock

Search interest for Greenwich LifeSciences Stock has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 24, 2026 to October 24, 2026

Change:-56% versus previous 30 day period

Greenwich LifeSciences Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	-	-	-	-
Operating Income	-2	-2	-2	-8	-2	-4	-4	-7	-5	-4
EBITDA	-2	-2	-2	-8	-2	-4	-4	-7	-5	-3
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	-	-	-	0
Income Before Tax	-2	-2	-2	-8	-2	-4	-4	-7	-5	-3
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-2	-2	-2	-8	-2	-4	-4	-7	-5	-3
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Greenwich LifeSciences Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0
Operating Income	-1	-1	-3	-1	-4	-8	-9	-17	-19
EBITDA	-1	-1	-3	-1	-4	-7	-8	-17	-19
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-1	-3	-1	-4	-7	-8	-17	-19
Income Tax Expense	0	-	-	-	-	-	-	-	-
Net Income	-1	-1	-3	-1	-4	-7	-8	-17	-19
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Greenwich LifeSciences Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-2	-2	-2	-8	-3	-4	-4	-7	-5	-3
Operating Cash Flow	-1	-1	-2	-1	-1	-2	-2	-3	-4	-1
Investing Cash Flow	-	-	-	-	-	-	-	-	-	-
Financing Cash Flow	0	2	1	0	0	2	3	5	9	0
Change in Cash	-1	1	-1	-1	-1	0	0	2	4	-1

Greenwich LifeSciences Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-1	-1	-3	-1	-4	-7	-8	-15	-19
Operating Cash Flow	0	0	0	-1	-4	-6	-6	-7	-9
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	0	0	0	29	2	-7	-	4	11
Change in Cash	0	0	0	28	-1	-13	-6	-2	2

Global Institutional Holdings in Greenwich LifeSciences

Check out the Institutions with significant holdings in Greenwich LifeSciences.

Funds	Holdings
Vanguard	2.62%
iShares	1.99%
VANGUARD INDEX FUNDS	1.98%
Fidelity Concord Street Trust	0.47%
Fidelity Salem Street Trust	0.46%

See all

Greenwich LifeSciences News & Key Events

Insights on Greenwich LifeSciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 year, GLSI stock has moved up by 68.4%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 157.7% return, outperforming this stock by 58.5%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 603.5%

About Greenwich LifeSciences

Greenwich LifeSciences, Inc. functions as a clinical-stage biopharmaceutical company, dedicated to developing innovative cancer immunotherapies. These treatments are primarily focused on breast cancer and other HER2/neu-positive malignancies. Its flagship therapeutic candidate is GP2, an immunotherapy which has successfully completed its Phase IIb clinical trials. This drug is designed to prevent the recurrence of breast cancer in patients who have already undergone surgical removal of the tumor. Founded in 2006 and based in Stafford, Texas, the company was formerly known as Norwell, Inc. until it rebranded to Greenwich LifeSciences, Inc. in March 2018.

Organisation	Greenwich LifeSciences
Headquarters	Building 14, Stafford, TX, 77477, US
Industry	Biotechnology
CEO	Snehal S. Patel

Key Management of Greenwich LifeSciences

Name	Title
Mr. Snehal S. Patel	CEO, CFO & Director
Mr. Eric Rothe	Founder & Independent Director
Dr. Frank Joseph Daugherty M.D.	Chief Medical Officer & Director
Dr. Jaye L. Thompson Ph.D.	Vice President Clinical & Regulatory Affairs
Dr. Christine T. Fischette Ph.D.	VP of Business Development

FAQs

What is Greenwich LifeSciences share price today?

Greenwich LifeSciences share price today is $15.79 as on October 24, 2026 at 12:51 am IST. Greenwich LifeSciences share today touched a day high of $16.09 and a low of $14.95.

What is the 52 week high and 52 week low for Greenwich LifeSciences share?

Greenwich LifeSciences share touched a 52 week high of $34.10 on January 27, 2026 and a 52 week low of $7.78 on November 24, 2025. Greenwich LifeSciences stock price today i.e. October 24, 2026 at 12:51 am IST is trending at $15.79,which is 53.70% down from its 52 week high and 102.96% up from its 52 week low.

What is Greenwich LifeSciences's market capitalisation today?

Greenwich LifeSciences market capitalisation is $0.00T as on October 24, 2026 at 12:51 am IST.

How to invest in Greenwich LifeSciences Stock (GLSI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Greenwich LifeSciences on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Greenwich LifeSciences Stock (GLSI) from India?

Indian investors can start investing in Greenwich LifeSciences (GLSI) shares with as little as ₹94.94000244140625 or $1 (as of October 24, 2026 at 12:52 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Greenwich LifeSciences stock (as per the Rupee-Dollar exchange rate as on October 24, 2026 at 12:52 am IST). Based on Greenwich LifeSciences share’s latest price of $15.79 as on October 24, 2026 at 12:51 am IST, you will get 0.6333 shares of Greenwich LifeSciences. Learn more about fractional shares .

What are the returns that Greenwich LifeSciences has given to Indian investors in the last 5 years?

Greenwich LifeSciences stock has given -56.33% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?